Premarket Mover: Marker Therapeutics Inc (MRKR) Down 7.30%

Marker Therapeutics Inc (MRKR) is down Thursday morning, with the stock falling -7.30% in pre-market trading to 1.65. MRKR's short-term technical score of 57 indicates that the stock has traded more bullishly over the last month than 57% of stocks on the market. In the Biotechnology industry, which ranks 73 out of 146 industries, MRKR ranks higher than 58% of stocks. Marker Therapeutics Inc has risen 81.63% over the past month, closing at $1.52 on May 4. During this period of time, the stock fell as low as $1.19 and as high as $1.71.

MRKR has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on MRKR!

See Full MRKR Report

Marker Therapeutics Inc has a Long-Term Technical rank of 61. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 39% of the market scoring higher. In the Biotechnology industry which is number 64 by this metric, MRKR ranks better than 64% of stocks.

Important Dates for Investors in MRKR:

-Marker Therapeutics Inc is set to release earnings on 8/14/2023. Over the last 12 months, the company has reported EPS of $-4.34. -We do not have a set dividend date for Marker Therapeutics Inc at this time. Click Here To Get The Full Report on Marker Therapeutics Inc (MRKR)